Showing results (871-880 of 1,601) with videos related to
Sort By:
Pageof 161
JAMA Dermatology|October 6, 2017
Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 ResultsDaniel J Lewis, Rakhshandra Talpur, Auris O Huen, et al.JAMA Dermatology|February 9, 2018
A Novel Severity Assessment Scoring System for Hidradenitis SuppurativaSchapoor Hessam, Lisa Scholl, Michael Sand, et al.JAMA Dermatology|March 22, 2018
Vascular Malformations and Health-Related Quality of Life: A Systematic Review and Meta-analysisHenry L Nguyen, George F Bonadurer, Megha M TollefsonJAMA Dermatology|January 10, 2019
Assessment of the Prevalence of Mucosal Involvement in Bullous PemphigoidKhalaf Kridin, Reuven BergmanJAMA Dermatology|December 6, 2018
Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US PopulationJennifer Pugh, Sikandar G Khan, Deborah Tamura, et al.JAMA Dermatology|December 27, 2018
Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection BiasAaron M Drucker, Wen-Qing Li, David A Savitz, et al.JAMA Dermatology|January 3, 2019
Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic ReviewCristian Navarrete-Dechent, Shoko Mori, Christopher A Barker, et al.JAMA Dermatology|December 27, 2018
Association of the POT1 Germline Missense Variant p.I78T With Familial MelanomaKim Wong, Carla Daniela Robles-Espinoza, David Rodriguez, et al.JAMA Dermatology|December 20, 2018
Trends in Medicare Utilization by Dermatologists, 2012-2015Jason Ya, Harib H Ezaldein, Jeffrey F ScottJAMA Dermatology|November 27, 2018
Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable MelanomaAbdulaali R Almutairi, Nimer S Alkhatib, Mok Oh, et al.Pageof 161